Ares Options Skew Hits Near-Annual Highs as Shorts Creep Back

ARES enters the first full post-earnings week at $128.93, up 5.5% on the week but down 3% on the final session, with options traders now the most defensively positioned they have been all year.

The standout signal this week is in the options market. The put/call ratio has jumped to 2.73, almost 2.7 standard deviations above its 20-day average of 2.49, and is approaching the 52-week high of 2.90. That is a meaningful shift from the pre-earnings reading noted in the previous note, when the ratio sat only about one standard deviation elevated. The move points to heavier demand for downside protection even after a print that the stock initially greeted with a 3.5% gain. Something in the post-earnings landscape is making options buyers more cautious, not less.

Short interest tells a consistent story. Bears have been adding quietly since earnings: short interest has risen 2.7% over the week to 7.4% of the free float, now back above the mid-October level of around 7.2%. The ORTEX short score has also crept upward, reaching 60.8 from 57.9 two weeks ago, its highest reading in the recent observation window. Borrow conditions are loose, availability is 255%, meaning roughly two-and-a-half shares remain available for every one already lent, and the cost to borrow at 0.51% remains historically low. There is no squeeze pressure in this setup. What there is instead is a gradual rebuilding of the short position from a base that was never particularly light.

The Street is broadly constructive but mixed on conviction. Almost every firm that updated targets after the Q3 print maintained a positive rating. RBC sits at $171, Barclays at $151, and TD Cowen at $158, all Buy-equivalent. JP Morgan kept its Overweight but trimmed one dollar to $154. The consensus mean is $146.55, implying roughly 14% upside from current levels. The bull case rests on $671.3 billion in total AUM, a floating-rate credit book that holds up in higher-rate environments, and a fundraising pipeline the company describes as building toward 2027. The bear case is more immediate: management trimmed 2026 guidance, FRE margin expansion now tracks only slightly above the midpoint of a 0 to 150 basis-point range, and carried interest guidance was cut to $300 million to $325 million from $350 million. The EPS surprise factor score of 20 and the analyst recommendation divergence rank of 6 both reflect a stock where the Street is more cautious than the headline ratings suggest. The 12-month forward EPS growth rank of 91, however, keeps the growth argument alive.

Ownership flows add context. BlackRock added 713,000 shares in the September quarter to hold 7.4% of shares, and State Street added 817,000 to reach 3.9%. T. Rowe Price made the most dramatic move, adding 3.4 million shares to bring its stake to 2.1%. These are passive and semi-active managers adding exposure, not conviction funds. Co-founder Antony Ressler's disclosed stake edged down to 33.1% from 34.2% in the most recent 13G/A, a drift consistent with prior gradual reduction rather than a sharp exit. No 13D activist is on the register. The Vanguard restructuring between entities is worth noting: The Vanguard Group filed a 13G/A showing zero shares, while Vanguard Capital Management and Vanguard Portfolio Management filed fresh 13Gs showing combined holdings above 7%, reflecting an internal reorganisation rather than any real change in economic exposure.

The next earnings event is not until February 5, 2027, leaving 93 days for the Street's 2027 optimism thesis, or the bears' near-term guidance concerns, to play out in the market. With options positioning near annual extremes and shorts slowly rebuilding, the tension to watch is whether the Q3 relief rally holds above the $128 to $129 range or whether the stock drifts back toward the guidance-cut narrative that weighed on it through much of the year.